Buried Metaplasia After Endoscopic Ablation of Barrett's Esophagus: A Systematic Review
- 1 November 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in American Journal Of Gastroenterology
- Vol. 106 (11), 1899-1908
- https://doi.org/10.1038/ajg.2011.255
Abstract
OBJECTIVES: Endoscopic ablation of Barrett's esophagus can bury metaplastic glands under a layer of neosquamous epithelium. To explore the frequency and importance of buried metaplasia, we have conducted a systematic review of reports on endoscopic ablation. METHODS: We performed computerized and manual searches for articles on the results of photodynamic therapy (PDT) and radiofrequency ablation (RFA) for Barrett's esophagus. We extracted information on the number of patients treated, biopsy protocol, biopsy depth, and frequency of buried metaplasia. RESULTS: We found 9 articles describing 34 patients with neoplasia appearing in buried metaplasia (31 after PDT). We found five articles describing a baseline prevalence of buried metaplasia (before ablation) ranging from 0% to 28%. In 22 reports on PDT for 953 patients, buried metaplasia was found in 135 (14.2%); in 18 reports on RFA for 1,004 patients, buried metaplasia was found in only 9 (0.9%). A major problem limiting the conclusions that can be drawn from these reports is that they do not describe specifically how frequently biopsy specimens contained sufficient subepithelial lamina propria to be informative for buried metaplasia. CONCLUSIONS: Endoscopic ablation can bury metaplastic glands with neoplastic potential but, even without ablation, buried metaplasia often is found in areas where Barrett's epithelium abuts squamous epithelium. Buried metaplasia is reported less frequently after RFA than after PDT. However, available reports do not provide crucial information on the adequacy of biopsy specimens and, therefore, the frequency and importance of buried metaplasia after endoscopic ablation remain unclear.This publication has 60 references indexed in Scilit:
- Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett's esophagus?Gastrointestinal Endoscopy, 2012
- Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagusGastrointestinal Endoscopy, 2010
- History, Molecular Mechanisms, and Endoscopic Treatment of Barrett's EsophagusGastroenterology, 2010
- Treatment of ultralong-segment Barrett’s using focal and balloon-based radiofrequency ablationSurgical Endoscopy, 2009
- Stem cells in Barrett's esophagus: HALOs or horns?Gastrointestinal Endoscopy, 2008
- Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registryGastrointestinal Endoscopy, 2008
- Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagusGastrointestinal Endoscopy, 2004
- Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term resultsGastrointestinal Endoscopy, 2003
- Photodynamic Therapy for Dysplastic Barrett Esophagus and Early Esophageal AdenocarcinomaMayo Clinic Proceedings, 2002